ompanies in the digital media, communications & mobility, enterprise and clean tech industries. Among its successes are Acme Packet, Amicus Therapeutics, Cerexa Inc., CommerceOne, DexCom Inc., DoubleClick, IntraLinks, Match.com, SuccessFactors and WebLoyalty. Other Canaan investments include Active Networks, AdvancedBioHealing, BharatMatrimony, BiPar Sciences, Blurb, Chimerix, Inc., N-trig, Prime Sense, ReVision Optics, Inc., Transoma Medical, Inc., Tremor Media and Xirrus. Canaan has offices in California, Connecticut, India and Israel. For more information, visit http://www.canaan.com/XQUOT;"
About Foundation Medical Partners
Foundation Medical Partners is a leading national, independent, healthcare venture capital investment firm. Foundation was formed in 2001 with the vision of bringing together cutting edge life science expertise with deep company-building experience. Foundation specializes in early stage investments in the medical device, biopharmaceutical, and predictive medicine technology sectors. Foundation is an active venture investor, providing leadership, support, and strategic resources at every stage in a company's development. Foundation Medical Partners invests in ventures that demonstrate the capability to improve the practice of medicine and human health.
For more information, visit http://www.foundmed.com/XQUOT;" target="_new">www.foundmed.com.
Company Contact Media Contact
John Krayacich Shirley Chow
Marinus Pharmaceuticals Porter Novelli Life Sciences
Page: 1 2 3 4 5 Related biology technology :1
|SOURCE Marinus Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer2
. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia3
. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 20084
. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS5
. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference6
. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ7
. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering8
. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments9
. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results10
. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results11
. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K